Home
Drugs
Capecitabine
Clinical Trials

Clinical Trials Related to Capecitabine

Related studies linked through entity extraction aliases.

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer

Status: NOT_YET_RECRUITING
Phase: PHASE2

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Status: RECRUITING
Phase: PHASE1

A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer

Status: UNKNOWN
Phase: PHASE1

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)

Status: UNKNOWN
Phase: PHASE2

ONO-4538 Phase II Rollover Study (ONO-4538-98)

Status: RECRUITING
Phase: PHASE2

Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer

Status: COMPLETED
Phase: PHASE2

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

PRECISE CURATE.AI Pilot Clinical Trial

Status: UNKNOWN
Phase: PHASE1/PHASE2

Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer

Status: COMPLETED
Phase: PHASE2

A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC

Status: RECRUITING
Phase: PHASE2

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer

Status: WITHDRAWN
Phase: PHASE3

Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer

Status: COMPLETED
Phase: PHASE2